Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 1/2022

12.03.2021 | Original Article

An assessment of race and gender-based biases among readmission predicting tools (HOSPITAL, LACE, and RAHF) in heart failure population

verfasst von: Manjari Rani Regmi, Priyanka Parajuli, Nitin Tandan, Mukul Bhattarai, Ruby Maini, Odalys Estefania Lara Garcia, Maryam Bakare, Abhishek Kulkarni, Robert Robinson

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

The objective of our study is to retrospectively investigate if the HOSPITAL score, LACE index, and RAHF scale exhibit any bias based on gender and race in heart failure readmissions.

Methods

This is a retrospective cohort study with all adult medical patients discharged with congestive heart failure from 2016 to 2018 from Southern Illinois University School of Medicine Hospitalist service. The receiver operating characteristic (ROC) curve was constructed comparing prediction tools (HOSPITAL score, LACE index, and RAHF scale) performance based on gender and race by measuring the area under the curve (AUC). Absolute Between-ROC Area (ABROCA) values were calculated. All statistical analyses were performed using R version 3.6.2.

Results

The performance of the HOSPITAL score in the majority and minority population showed a statistically significant difference between AUCs (0.714 and 0.633, p = 0.029) and an ABROCA of 0.081 indicating superior performance in predicting hospital readmissions in the majority group vs. the minority. The performance of RAHF score in females and males showed statistically significant differences between AUCs (0.567 and 0.527, p = 0.04) and an ABROCA of 0.04 indicating the superior performance of the RAHF score in females compared with males.

Conclusions

Our study demonstrated that the HOSPITAL score and the RAHF scale showed significant differences in predicting 30-day readmissions risk based on race and gender, respectively, in heart failure patients, whereas the LACE index did not show any significant difference.
Literatur
1.
Zurück zum Zitat Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodríguez JA et al (2017) Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data. Int J Cardiol 248:246–251CrossRef Fernandez-Gasso L, Hernando-Arizaleta L, Palomar-Rodríguez JA et al (2017) Trends, causes and timing of 30-day readmissions after hospitalization for heart failure: 11-year population-based analysis with linked data. Int J Cardiol 248:246–251CrossRef
2.
Zurück zum Zitat Auerbach AD, Kripalani S, Vasilevskis EE et al (2016) Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA internal medicine 176(4):484–493CrossRef Auerbach AD, Kripalani S, Vasilevskis EE et al (2016) Preventability and causes of readmissions in a national cohort of general medicine patients. JAMA internal medicine 176(4):484–493CrossRef
3.
Zurück zum Zitat Park, Christopher et al. (2019) Impact on readmission reduction among heart failure patients using digital health monitoring: feasibility and adoptability study. JMIR medical informatics 7.4: e13353. Park, Christopher et al. (2019) Impact on readmission reduction among heart failure patients using digital health monitoring: feasibility and adoptability study. JMIR medical informatics 7.4: e13353.
4.
Zurück zum Zitat Donzé, Jacques D et al. (2016) cs. JAMA internal medicine 176.4: 496–502. Donzé, Jacques D et al. (2016) cs. JAMA internal medicine 176.4: 496–502.
5.
Zurück zum Zitat Van Walraven, Carl, et al. (2010) Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. Cmaj 182.6: 551–557. Van Walraven, Carl, et al. (2010) Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community. Cmaj 182.6: 551–557.
6.
Zurück zum Zitat Chamberlain RS, Sond J, Mahendraraj K et al (2018) Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale. International journal of general medicine 11:127CrossRef Chamberlain RS, Sond J, Mahendraraj K et al (2018) Determining 30-day readmission risk for heart failure patients: the Readmission After Heart Failure scale. International journal of general medicine 11:127CrossRef
7.
Zurück zum Zitat Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22(suppl A):6A-13ACrossRef Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 22(suppl A):6A-13ACrossRef
8.
Zurück zum Zitat Simon T, Mary-Krause M, Bunck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure. Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001;103:375–80. Simon T, Mary-Krause M, Bunck-Brentano C, Jaillon P, on behalf of the CIBIS II Investigators. Sex differences in the prognosis of congestive heart failure. Results from the Cardiac Insufficiency Bisoprolol Study (CIBIS II). Circulation 2001;103:375–80.
9.
Zurück zum Zitat Ghali JK, Pina IL, Gottlieb SS et al (2002) Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105:1585–1591CrossRef Ghali JK, Pina IL, Gottlieb SS et al (2002) Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF). Circulation 105:1585–1591CrossRef
10.
Zurück zum Zitat Galvao M, Kalman J, DeMarco T et al (2006) Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Cardiac Fail 12(2):100–107CrossRef Galvao M, Kalman J, DeMarco T et al (2006) Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Cardiac Fail 12(2):100–107CrossRef
11.
Zurück zum Zitat Philbin EF, DiSalvo TG (1998) Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. The American journal of cardiology 82(1):76–81CrossRef Philbin EF, DiSalvo TG (1998) Influence of race and gender on care process, resource use, and hospital-based outcomes in congestive heart failure. The American journal of cardiology 82(1):76–81CrossRef
12.
Zurück zum Zitat Kwok CS, Potts J, Gulati M et al (2018) Effect of gender on unplanned readmissions after percutaneous coronary intervention (from the Nationwide Readmissions Database). The American journal of cardiology 121(7):810–817CrossRef Kwok CS, Potts J, Gulati M et al (2018) Effect of gender on unplanned readmissions after percutaneous coronary intervention (from the Nationwide Readmissions Database). The American journal of cardiology 121(7):810–817CrossRef
13.
Zurück zum Zitat Evangelista LS, Dracup K, Doering LV (2002) Racial differences in treatment-seeking delays among heart failure patients. J Cardiac Fail 8(6):381–386CrossRef Evangelista LS, Dracup K, Doering LV (2002) Racial differences in treatment-seeking delays among heart failure patients. J Cardiac Fail 8(6):381–386CrossRef
Metadaten
Titel
An assessment of race and gender-based biases among readmission predicting tools (HOSPITAL, LACE, and RAHF) in heart failure population
verfasst von
Manjari Rani Regmi
Priyanka Parajuli
Nitin Tandan
Mukul Bhattarai
Ruby Maini
Odalys Estefania Lara Garcia
Maryam Bakare
Abhishek Kulkarni
Robert Robinson
Publikationsdatum
12.03.2021
Verlag
Springer International Publishing
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 1/2022
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-021-02519-0

Weitere Artikel der Ausgabe 1/2022

Irish Journal of Medical Science (1971 -) 1/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.